文献速递临床生化临床免疫

完整与胰蛋白酶消化后IGF-1 LC-MS法实验室间一致性研究

Inter-Laboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured Intact by Mass Spectrometry.
PubMed 文献 · Clin Chem · 2020-01-01

该研究在五个实验室用LC-MS测定32份血清中完整及胰蛋白酶消化的IGF-1,并与单实验室免疫测定比较,另在每实验室用LC-MS测定100份样本的完整与消化IGF-1。结果显示实验室内变异为2-4% CV,实验室间变异为14.5% CV;两种LC-MS法统计无差异且与免疫测定相似,建议以完整与消化IGF-1测定结果相差在20%以内作为方法可接受标准。

要点

  • LC-MS测定完整与胰蛋白酶消化IGF-1两种方法结果统计无差异。
  • 实验室间变异为14.5% CV,实验室内变异为2-4% CV。
  • 建议完整与消化IGF-1测定结果相差在20%以内作为可接受标准。

核心结论

  • LC-MS测定完整与胰蛋白酶消化IGF-1方法统计无差异,且各自与免疫测定相似。
  • 两种LC-MS方法可互换或联合使用,以消除对免疫测定IGF-1的担忧。
  • 完整与消化IGF-1测定结果一般在20%以内一致,建议作为方法可接受标准。

研究设计与样本

  • 五个实验室用不同仪器以LC-MS分析32份血清样本(来自健康志愿者及人生长激素给药研究)的完整与胰蛋白酶消化IGF-1,并由单一实验室行免疫测定。
  • 每个实验室另用LC-MS分析100份样本的完整与消化IGF-1。

主要发现

  • 实验室内变异为2-4% CV。
  • 实验室间变异为14.5% CV。
  • 完整法与消化法正交回归(n=646)斜率为1.01,截距为2.05 ng/mL。

关键数值与推荐

  • 在预期血IGF-1范围(约50-500 ng/mL)内,先前实验室间研究显示消化蛋白LC-MS测定的不精密度为11% CV。
  • 完整与消化IGF-1测定结果一般在20%以内一致,建议作为方法可接受标准。

临床怎么用

  • LC-MS测定IGF-1的完整与消化方法可互换或联合使用,用于GH紊乱诊断治疗及运动中人GH滥用检测。
  • 采用完整与消化IGF-1结果相差在20%以内作为方法可接受标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Insulin-like growth factor-I (IGF-1) is measured mainly by immunoassay for the diagnosis and treatment of growth hormone (GH) disorders, and to detect misuse of GH in sport. Immunoassays often have insufficient inter-laboratory agreement, especially between commercial kits. Over the expected range of IGF-1 in blood (∼50-500 ng/mL), in an inter-laboratory study we previously established a measurement imprecision of 11% (%CV) for the digested protein analyzed by LC-MS. Measuring intact IGF-1 by LC-MS should be simpler. However, no inter-laboratory agreement has been published. METHODS: Intact and trypsin-digested IGF-1 in 32 serum samples from healthy volunteers and human growth hormone administration studies were analyzed by LC-MS using different instruments in five laboratories, as well as by immunoassay in a single laboratory. Another 100 samples were analyzed for IGF-1, both intact and after trypsin-digestion, in each laboratory by LC-MS. The statistical relationship between measurements and the imprecision of each assay group was assessed. RESULTS: An intra-laboratory variability of 2-4% CV was obtained. Inter-laboratory variability was greater at 14.5% CV. Orthogonal regression of intact versus trypsin-digestion methods (n = 646) gave a slope of 1.01 and intercept of 2.05 ng/mL. CONCLUSIONS: LC-MS measurements of IGF-1 by intact and trypsin-digestion methods are not statistically different and each is similar to immunoassay. The two LC-MS approaches may be used interchangeably or together to eliminate concerns regarding an immunoassay IGF-1 measurement. Because intact and digested IGF-1 measurements generally agreed within 20% of each other, we propose this as a criterion of assay acceptability.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Moncrieffe D, Cox HD, Carletta S, et al. Inter-Laboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured Intact by Mass Spectrometry. Clin Chem. 2020. PMID: 32232452. doi:10.1093/clinchem/hvaa043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。